• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Chinese Insurtech Startup Carevoice Lands Roughly $10M

Share:

August 26, 2019

This morning Shanghai-based CareVoice, digital health startup targeting the insurance market, announced an eight-figure Series A raise totaling roughly $10 million, according to the startup. The new cash round was led by LUN Partners Group with participation from DNA Capital, SoSV and Artesian Capital.

This comes about a year and a half after the company announced a $2 million raise in yearly-stage funding.

WHAT THEY DO

Carevoice’s tool was developed so that the patient consumer could view the differences in both cost and quality. Carevoice also partners with insurers to provide mobile-based SaaS tool to their members. Through different partnerships with tech startups, it has been expanding its features and now includes an AI-based virtual nurse and fraud protection.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Most recently, the company launched CareVoiceOS, an operating system for payers that lets them make tailored insurance plans on the technology.

The company started out in mainland China, where private healthcare and private health insurance are both still relatively young markets, and more recently launched in Hong Kong.

“Health insurance is the new growth engine for insurance in China,” Sebastien Gaudin, CEO of CareVoice, told MobiHealthNews.

While most Chinese citizens are covered under public health plans, for the most part those plans only cover the basics like visits with a primary care provide, he said. This has led to the growth of private insurers in China, Gaudin said.

“China is leap frogging a lot in many industries and getting ahead of other markets. It’s interesting in health insurance because it is a quite new market,” he said.

So far the company has made partnerships with 15 different insurance companies and plans to expand across Asia.

WHAT IT’S FOR

The company said it has three main focuses. The first is investing in research and development for its digital platform. It also plans on using the funds to expand its sales and customer success teams and international business development efforts. Lastly, it plans to launch 10 new health insurtech products.

MARKET SNAPSHOT

The payer market is quickly gaining traction in China. Perhaps the most notable in the space is Ping An Good Doctor a “one stop” health ecosystem. The company has quickly been launching new products. Earlier this week the it launched its Private Doctor Service, which will connect clients to 24-7 online consultations, second-round consultations, offline clinical arrangement, health management and chronic disease management.

Carevoice counts the insurance giant among its current clients.

ON THE RECORD

“We foresee that insurance will be the next sector to experience the highest growth of digitalization and innovation as well as the arrival of new fintech unicorn companies.” Peilung Li, founder and chairman of LUN Partners Group, said in a statement. “CareVoice is driving digitalization and innovation for insurance companies, and we are very confident about its development in the Greater China market. To further aid the Company’s growth, LUN Partners will help CareVoice extend its proven digitalization solutions to overseas insurance marketplaces in Japan, Southeast Asia and other regions.”

Date: August 26, 2019

Source: Healthvox

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Fitbit and Health2Synch Partner Up for Diabetes ManagementFitbit and Health2Synch Partner Up for Diabetes Management
  • Pacific Biosciences Signs Definitive Agreement to Acquire OmniomePacific Biosciences Signs Definitive Agreement to Acquire Omniome
  • The 7 Most Interesting Things Business Leaders Told Us in 2018The 7 Most Interesting Things Business Leaders Told Us in 2018
  • Change Healthcare Acquires Cloud-Native Imaging Platform Nucleus.ioChange Healthcare Acquires Cloud-Native Imaging Platform Nucleus.io
  • Bayer completes biggest acquisition in its historyBayer completes biggest acquisition in its history
  • Building An Interstate Regulatory Framework for TelemedicineBuilding An Interstate Regulatory Framework for Telemedicine
  • Join West Monroe at the 5th Fall Investment and M&A Opportunities in Healthcare ConferenceJoin West Monroe at the 5th Fall Investment and M&A Opportunities in Healthcare Conference
  • NVIDIA Partners with AstraZeneca and the University of Florida for AI-Powered Drug DiscoveryNVIDIA Partners with AstraZeneca and the University of Florida for AI-Powered Drug Discovery

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications